The drug company's sales was down around 50 percent to Rs 184 crore. During the period, its profit too shrunk to Rs 84.3 lakh compared to Rs 18 crore on lower sales and a higher finance cost.
first published: Aug 30, 2013 02:30 pm
A collection of the most-viewed Moneycontrol videos.

India–US Trade Deal Is Here! Markets Explode, Rupee Soars | What Changes Now?

Live: Sensex, Nifty jumps 2% on India-US deal optimism, Rupees firms up | Closing Bell

India-US Trade Deal Set To Ignite The Bulls| GIFT NIFTY Signals 1000+ Point Gap Up | Opening Bell Live

Exclusive Post-Budget Interview: FM Sitharaman in Conversation with Rahul Joshi
You are already a Moneycontrol Pro user.